"tisagenlecleucel" meaning in All languages combined

See tisagenlecleucel on Wiktionary

Noun [English]

IPA: /ˌtɪsəd͡ʒɛnləˈkluːsəl/, /ˌtɪsəd͡ʒɛnˈlɛkluːsəl/
Etymology: From tisa- (unique name) + -gen- (“transfer of genetic material (transduced)”) + -lec- (“selection and enrichment manipulation”) + -leu- (“leukocytes”) + -cel (“cellular therapy”). Etymology templates: {{affix|en|alt1=tisa-|alt2=-gen-|alt3=-lec-|alt4=-leu-|alt5=-cel|pos1=unique name|t2=transfer of genetic material (transduced)|t3=selection and enrichment manipulation|t4=leukocytes|t5=cellular therapy}} tisa- (unique name) + -gen- (“transfer of genetic material (transduced)”) + -lec- (“selection and enrichment manipulation”) + -leu- (“leukocytes”) + -cel (“cellular therapy”) Head templates: {{en-noun|-}} tisagenlecleucel (uncountable)
  1. (pharmacology) An anti-CD19 CAR-T cell therapy used in the treatment of haematological malignancies. Tags: uncountable Categories (topical): Pharmaceutical drugs Related terms: axicabtagene ciloleucel
    Sense id: en-tisagenlecleucel-en-noun-Jxsal4dB Categories (other): English entries with incorrect language header, Pages with 1 entry, Pages with entries Topics: medicine, pharmacology, sciences
{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "alt1": "tisa-",
        "alt2": "-gen-",
        "alt3": "-lec-",
        "alt4": "-leu-",
        "alt5": "-cel",
        "pos1": "unique name",
        "t2": "transfer of genetic material (transduced)",
        "t3": "selection and enrichment manipulation",
        "t4": "leukocytes",
        "t5": "cellular therapy"
      },
      "expansion": "tisa- (unique name) + -gen- (“transfer of genetic material (transduced)”) + -lec- (“selection and enrichment manipulation”) + -leu- (“leukocytes”) + -cel (“cellular therapy”)",
      "name": "affix"
    }
  ],
  "etymology_text": "From tisa- (unique name) + -gen- (“transfer of genetic material (transduced)”) + -lec- (“selection and enrichment manipulation”) + -leu- (“leukocytes”) + -cel (“cellular therapy”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "tisagenlecleucel (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Healthcare",
            "Fundamental",
            "Health",
            "Body"
          ],
          "source": "w"
        }
      ],
      "glosses": [
        "An anti-CD19 CAR-T cell therapy used in the treatment of haematological malignancies."
      ],
      "id": "en-tisagenlecleucel-en-noun-Jxsal4dB",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "CD19",
          "CD19"
        ],
        [
          "CAR-T cell",
          "CAR-T cell"
        ],
        [
          "therapy",
          "therapy"
        ],
        [
          "haematological",
          "haematological"
        ],
        [
          "malignancies",
          "malignancy"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) An anti-CD19 CAR-T cell therapy used in the treatment of haematological malignancies."
      ],
      "related": [
        {
          "word": "axicabtagene ciloleucel"
        }
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌtɪsəd͡ʒɛnləˈkluːsəl/"
    },
    {
      "ipa": "/ˌtɪsəd͡ʒɛnˈlɛkluːsəl/"
    }
  ],
  "word": "tisagenlecleucel"
}
{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "alt1": "tisa-",
        "alt2": "-gen-",
        "alt3": "-lec-",
        "alt4": "-leu-",
        "alt5": "-cel",
        "pos1": "unique name",
        "t2": "transfer of genetic material (transduced)",
        "t3": "selection and enrichment manipulation",
        "t4": "leukocytes",
        "t5": "cellular therapy"
      },
      "expansion": "tisa- (unique name) + -gen- (“transfer of genetic material (transduced)”) + -lec- (“selection and enrichment manipulation”) + -leu- (“leukocytes”) + -cel (“cellular therapy”)",
      "name": "affix"
    }
  ],
  "etymology_text": "From tisa- (unique name) + -gen- (“transfer of genetic material (transduced)”) + -lec- (“selection and enrichment manipulation”) + -leu- (“leukocytes”) + -cel (“cellular therapy”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "tisagenlecleucel (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "related": [
    {
      "word": "axicabtagene ciloleucel"
    }
  ],
  "senses": [
    {
      "categories": [
        "English compound terms",
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English uncountable nouns",
        "Pages with 1 entry",
        "Pages with entries",
        "en:Pharmaceutical drugs"
      ],
      "glosses": [
        "An anti-CD19 CAR-T cell therapy used in the treatment of haematological malignancies."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "CD19",
          "CD19"
        ],
        [
          "CAR-T cell",
          "CAR-T cell"
        ],
        [
          "therapy",
          "therapy"
        ],
        [
          "haematological",
          "haematological"
        ],
        [
          "malignancies",
          "malignancy"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) An anti-CD19 CAR-T cell therapy used in the treatment of haematological malignancies."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌtɪsəd͡ʒɛnləˈkluːsəl/"
    },
    {
      "ipa": "/ˌtɪsəd͡ʒɛnˈlɛkluːsəl/"
    }
  ],
  "word": "tisagenlecleucel"
}

Download raw JSONL data for tisagenlecleucel meaning in All languages combined (1.8kB)


This page is a part of the kaikki.org machine-readable All languages combined dictionary. This dictionary is based on structured data extracted on 2025-01-25 from the enwiktionary dump dated 2025-01-20 using wiktextract (c15a5ce and 5c11237). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.

If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.